+

NO20016211L - Prevensjon av type 1 diabetes og andre ikke-polio enterovirussykdommer - Google Patents

Prevensjon av type 1 diabetes og andre ikke-polio enterovirussykdommer

Info

Publication number
NO20016211L
NO20016211L NO20016211A NO20016211A NO20016211L NO 20016211 L NO20016211 L NO 20016211L NO 20016211 A NO20016211 A NO 20016211A NO 20016211 A NO20016211 A NO 20016211A NO 20016211 L NO20016211 L NO 20016211L
Authority
NO
Norway
Prior art keywords
type
opv
prevention
killed
polio
Prior art date
Application number
NO20016211A
Other languages
English (en)
Other versions
NO20016211D0 (no
NO328680B1 (no
Inventor
Heikki Hyoety
Mikael Knip
Original Assignee
Mikael Knip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikael Knip filed Critical Mikael Knip
Publication of NO20016211D0 publication Critical patent/NO20016211D0/no
Publication of NO20016211L publication Critical patent/NO20016211L/no
Publication of NO328680B1 publication Critical patent/NO328680B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Levende virusvaksiner som omfatter svekkede vimser, mens andre vaksiner omfatter avlivede vimser eller deler derav. Det er nu funnet at immunresponsen som induseres av oralpoliovirusvaksine (OPV) som er en levende vaksine, er kryssreaktiv med ikke-polio enteroviruser. OPV er derfor brukbar ved prevensjon av ikke-polio enterovirussyk-dommer, særlig type 1 diabetes mellitus (IDDM). OPV er også brukbar i kombinasjon med avlivede/subenhet ikke-polio enterovimsvaksiner, hvorved den forhindrer skadeli-ge bivirkninger av den avlivede/subenhetvaksine ved å skifte immunresponsen fra en skadelig Th2-type-respons til en Thl-type-respons.
NO20016211A 1999-06-24 2001-12-18 Anvendelse av oral poliovirusvaksine (OPV) og ikke-polio enterovirusvaksine mot ikke-polio virussykdommer slik som type 1 diabetes og et vaksinepreparat omfattende nevnte virus. NO328680B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14087299P 1999-06-24 1999-06-24
PCT/FI2000/000220 WO2001000236A1 (en) 1999-06-24 2000-03-17 Prevention of type 1 diabetes and other non-polio enterovirus diseases

Publications (3)

Publication Number Publication Date
NO20016211D0 NO20016211D0 (no) 2001-12-18
NO20016211L true NO20016211L (no) 2002-02-20
NO328680B1 NO328680B1 (no) 2010-04-26

Family

ID=22493179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016211A NO328680B1 (no) 1999-06-24 2001-12-18 Anvendelse av oral poliovirusvaksine (OPV) og ikke-polio enterovirusvaksine mot ikke-polio virussykdommer slik som type 1 diabetes og et vaksinepreparat omfattende nevnte virus.

Country Status (10)

Country Link
EP (1) EP1187631B1 (no)
AT (1) ATE276761T1 (no)
AU (1) AU770922B2 (no)
CA (1) CA2376923C (no)
DE (1) DE60014077T2 (no)
DK (1) DK1187631T3 (no)
ES (1) ES2228481T3 (no)
NO (1) NO328680B1 (no)
PT (1) PT1187631E (no)
WO (1) WO2001000236A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8961982B2 (en) * 2005-12-16 2015-02-24 The Regents Of The University Of California Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
FI20075063A0 (fi) 2007-02-01 2007-02-01 Vactech Oy Allergisen herkistymisen estäminen
FI20075861A0 (fi) 2007-11-30 2007-11-30 Vactech Oy Enteroviruksen käyttö taudin diagnostiikassa, hoidossa ja ehkäisyssä
WO2010032976A2 (ko) * 2008-09-17 2010-03-25 광주과학기술원 심부전 예방 또는 치료용 조성물
ES2614251T3 (es) 2010-07-01 2017-05-30 Vactech Oy Análisis de diagnóstico para diabetes tipo 1
EP2402028A1 (en) 2010-07-01 2012-01-04 Sanofi Pasteur Enterovirus vaccines for preventing and treating type 1 diabetes (II)
EP2402027A1 (en) 2010-07-01 2012-01-04 Sanofi Pasteur Enterovirus vaccines for preventing or treating type 1 diabetes (I)
EP2402029A1 (en) 2010-07-01 2012-01-04 Sanofi Pasteur Enterovirus vaccines for preventing or treating type 1 diabetes (III)
EP2583688A1 (en) 2011-10-18 2013-04-24 Sanofi Pasteur Multi-CBV vaccine for preventing or treating type 1 diabetes
CA2859684C (en) 2011-11-18 2020-02-11 Colin Dunlop A method and apparatus for facilitating delivery of anaesthetic
US20140271718A1 (en) 2013-03-15 2014-09-18 University Of Florida Research Foundation Incorporated Novel type 1 diabetes vaccines, and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728385A (en) * 1993-08-12 1998-03-17 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae

Also Published As

Publication number Publication date
ES2228481T3 (es) 2005-04-16
AU3436600A (en) 2001-01-31
CA2376923C (en) 2014-08-05
AU770922B2 (en) 2004-03-11
ATE276761T1 (de) 2004-10-15
EP1187631A1 (en) 2002-03-20
DE60014077D1 (de) 2004-10-28
DK1187631T3 (da) 2005-01-24
DE60014077T2 (de) 2005-10-20
PT1187631E (pt) 2005-01-31
CA2376923A1 (en) 2001-01-04
NO20016211D0 (no) 2001-12-18
WO2001000236A1 (en) 2001-01-04
EP1187631B1 (en) 2004-09-22
NO328680B1 (no) 2010-04-26

Similar Documents

Publication Publication Date Title
NO20016211L (no) Prevensjon av type 1 diabetes og andre ikke-polio enterovirussykdommer
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
NO940660L (no) HLA - begrensete Hepatit B virus CTL-epitoper
ATE358722T1 (de) Kälte-adaptierte pferde influenza-viren
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
DK1255815T3 (da) Porcint reproduktivt og respiratorisk syndromvirus til fremgangsmåder til anvendelse
WO2001060849A3 (en) Cold-adapted equine influenza viruses
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
RS20070078A (en) Inactivated poliomyelitis vaccine derived from sabin strain of polio virus
JP2006512078A5 (no)
RU2004115107A (ru) Способы профилактики и лечения инфекции, вызываемой флавивирусами у животных
WO2001097824A3 (de) Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch flaviviridae
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
WO2001074386A3 (en) Cold-adapted equine influenza viruses
ATE89860T1 (de) Attenuierte viren.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
BR0101523A (pt) Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus
ATE373675T1 (de) Impfstoff gegen pferdearteritisvirus
WO2004039402A3 (es) Prevención y tratamiento del síndrome respiratorio y reproductivo del cerdo con el uso de immunoglobulinas obtenidas de la yema de huevo proveniente de gallinas hiperinmunizadas con el virus de prrs
Centers for Disease Control and Prevention (CDC Progress toward poliomyelitis eradication--Myanmar, 1996-1999
Esparza et al. Vaccine briefing
RU2002118650A (ru) Штамм № 1737/Грузия/2000 вируса ящура типа Азия-1 для изготовления диагностических и вакцинных препаратов

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载